CSBR
Champions Oncology, Inc. - Common Stock (CSBR)
$26
About Champions Oncology, Inc. - Common Stock (CSBR)
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.
Details
Daily high
$5.30
Daily low
$5.08
Price at open
$5.30
52 Week High
$8.31
52 Week Low
$4.59
Market cap
73.8M
Dividend yield
-
Volume
9,398
Avg. volume
13,194
P/E ratio
-66.08
Champions Oncology, Inc. - Common Stock News
Details
Daily high
$5.30
Daily low
$5.08
Price at open
$5.30
52 Week High
$8.31
52 Week Low
$4.59
Market cap
73.8M
Dividend yield
-
Volume
9,398
Avg. volume
13,194
P/E ratio
-66.08